U.S. prices of Imbruvica compared to prices in select countries 2020

In 2020, both the estimated U.S. net price and gross price for a one-month supply (90 capsules) of Imbruvica Oral Capsule (140mg) were roughly two times higher than gross prices paid in the comparison countries. Imbruvica is a cancer medicine used to treat chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenstrom's Macroglobulinemia.This statistic shows Imbruvica's net and gross prices in the United States compared to gross prices in Australia, Canada, and France as of 2020.

2020年，美国Imbruvica口服胶囊（140mg）一个月供应量（90粒）的估计净价和毛价均约为比较国家支付毛价的两倍。Imbruvica是一种用于治疗慢性淋巴细胞白血病、浆细胞瘤和华氏巨球蛋白血症的抗癌药物。本统计数据展示了2020年Imbruvica在美国的净价与毛价，与澳大利亚、加拿大和法国的毛价进行比较。